• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清反应阳性个体尿液中的HIV-1中和抗体。

HIV-1 neutralizing antibodies in urine from seropositive individuals.

作者信息

Cao Y Z, Friedman-Kien A E, Mirabile M, Li X L, Alam M, Dieterich D, Ho D D

机构信息

Department of Microbiology, New York University Medical Center, NY 10016.

出版信息

J Acquir Immune Defic Syndr (1988). 1990;3(3):195-9.

PMID:1968094
Abstract

HIV-1 neutralizing activity was demonstrated in serum and 200-fold concentrated urine from individuals who were HIV-1 antibody positive in both their serum and urine, including AIDS-KS, AIDS-OI, ARC, and asymptomatic patients. Virus neutralization activity was detected in 23 of 56 (41.1%) of the serum samples and in 19 of 56 (33.9%) of the urine samples tested, with titers ranging from 1:8 to 1:256 and 1:1 to 1:4, respectively. The highest frequency of HIV-1 neutralizing activity (87.5%) and the highest mean neutralization titers (1:65) were found in the ARC patients. A high prevalence of p24 antigen in serum and low numbers of T4-lymphocytes correlated with a low frequency of neutralizing activity in either serum or urine in the infected individuals. HIV-1 neutralizing activity in the urine was shown to be due to immunoglobulins using a Sephadex G-100 filtration gel. All 19 urine samples with neutralizing activity contained antibodies reactive with envelope glycoproteins gp160, gp120, and gp41 by Western blot, similar to that seen with serum. The frequency of HIV-1 neutralizing activity in the urine concentrates was generally associated with high titers of neutralizing antibody in the corresponding serum. These findings suggest that HIV-1 neutralizing antibodies are lost in the urine by an as yet unknown mechanism.

摘要

在血清和尿液中均呈HIV-1抗体阳性的个体(包括患艾滋病相关卡波西肉瘤、艾滋病相关机会性感染、艾滋病相关综合征及无症状患者)的血清和浓缩200倍的尿液中,均检测到了HIV-1中和活性。在检测的56份血清样本中有23份(41.1%)以及56份尿液样本中有19份(33.9%)检测到病毒中和活性,其效价分别为1:8至1:256和1:1至1:4。艾滋病相关综合征患者中HIV-1中和活性的频率最高(87.5%),平均中和效价也最高(1:65)。血清中p24抗原的高流行率以及T4淋巴细胞数量少与受感染个体血清或尿液中中和活性的低频率相关。使用葡聚糖G-100过滤凝胶显示,尿液中的HIV-1中和活性是由免疫球蛋白引起的。通过蛋白质印迹法,所有19份具有中和活性的尿液样本均含有与包膜糖蛋白gp160、gp120和gp41反应的抗体,这与血清中的情况类似。尿液浓缩物中HIV-1中和活性的频率通常与相应血清中高滴度的中和抗体相关。这些发现表明,HIV-1中和抗体通过一种尚不清楚的机制在尿液中丢失。

相似文献

1
HIV-1 neutralizing antibodies in urine from seropositive individuals.血清反应阳性个体尿液中的HIV-1中和抗体。
J Acquir Immune Defic Syndr (1988). 1990;3(3):195-9.
2
[Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].[采用蛋白质印迹法检测血清学阳性吸毒者中抗HIV-1蛋白抗体的诊断价值]
Przegl Epidemiol. 1992;46(1-2):19-25.
3
Specific western blot bands are associated with initial CD4+ lymphocyte counts in human immunodeficiency virus seroconverters. The Navy HIV Working Group.特定的蛋白质印迹条带与人类免疫缺陷病毒血清转化者最初的CD4 +淋巴细胞计数相关。海军艾滋病毒工作组。
Ann Epidemiol. 1994 Jan;4(1):27-31. doi: 10.1016/1047-2797(94)90039-6.
4
Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage.腮腺唾液中针对1型人类免疫缺陷病毒的分泌性抗体随HIV-1疾病阶段的变化。
AIDS Res Hum Retroviruses. 1990 Jul;6(7):933-41. doi: 10.1089/aid.1990.6.933.
5
Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.使用重组p24、gp41、gp120和gp36抗原评估一种用于确认1型和2型人类免疫缺陷病毒感染的新型斑点印迹检测法。
Saudi Med J. 2006 Jan;27(1):31-6.
6
Quantitative analysis of human immunodeficiency virus type 1 antibody reactivity by western immunoblots: evaluation of relative antibody levels in seropositive individuals and mothers.通过免疫印迹法对1型人类免疫缺陷病毒抗体反应性进行定量分析:血清阳性个体和母亲中相对抗体水平的评估
J Infect Dis. 1992 Jan;165(1):111-8. doi: 10.1093/infdis/165.1.111.
7
Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.通过酶免疫测定法对重组HIV-1 gp160疫苗的血清抗体反应进行表征。美国国立过敏与传染病研究所艾滋病疫苗临床试验网络。
AIDS Res Hum Retroviruses. 1990 Nov;6(11):1251-6. doi: 10.1089/aid.1990.6.1251.
8
[Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].[血液抗原以及特异性抗核心抗体和抗包膜抗体作为HIV感染病程的标志物]
Boll Ist Sieroter Milan. 1989;68(2):115-21.
9
Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.采用重组(p24、p66、gp120)和合成(gp41)病毒抗原肽的抗HIV ELISA的敏感性和特异性。
Microbiologica. 1991 Jul;14(3):185-94.
10
Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.通过中和及结合试验评估针对HIV-1包膜的单克隆抗体:一项国际合作。
AIDS. 1994 Feb;8(2):169-81.

引用本文的文献

1
Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.对A、B、C、D、E、F和I型人类免疫缺陷病毒1型血清中和作用的定量分析:中和血清型与基因亚型之间缺乏直接相关性以及存在普遍的血清依赖性感染性增强的证据。
J Virol. 1996 Jan;70(1):445-58. doi: 10.1128/JVI.70.1.445-458.1996.
2
Phase I/II vaccination study of recombinant peptide F46 corresponding to the HIV-1 transmembrane protein coupled with 2.4 dinitrophenyl (DNP) Ficoll.与2,4-二硝基苯基(DNP)-菲可耦合的、对应于HIV-1跨膜蛋白的重组肽F46的I/II期疫苗研究
Infection. 1994 Mar-Apr;22(2):86-91. doi: 10.1007/BF01739010.